Skip to Content

Dermaxon Logo Dermaxon

Further exploring the brain-skin connection for a better life

March 2016

DermaXon Announces Publication of Article Describing Development and Characterization of Novel and Selective Inhibitors of Cytochrome P450 CYP26. Abstract

DermaXon Announces Publication of Article Showing Tazarotenic Acid is Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1. Abstract

< Back to News
^ Back to Top ^ Back to Top
MENU